EX-FILING FEES 2 d783925dexfilingfees.htm EX-FILING FEES EX-FILING FEES

Exhibit 107

Calculation of Filing Fee Tables

424b5

(Form Type)

Intellia Therapeutics, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities

 

                         
     Security
Type
  Security
Class
Title
  Fee
Calculation
or Carry
Forward
Rule
  Amount
Registered
  Proposed
Maximum
Offering
Price Per
Unit (1)
  Maximum
Aggregate
Offering Price
  Fee Rate   Amount of
Registration
Fee (4)
  Carry
Forward
Form
Type
  Carry
Forward
File
Number
  Carry
Forward
Initial
Effective
Date
  Filing Fee
Previously
Paid In
Connection
with
Unsold
Securities
to
be Carried
Forward
 
Newly Registered Securities
                     
    Primary Offering of Securities:                    
                         
Fees to Be Paid   Equity  

Common

Stock,

par value

$0.0001 per

share

  457(o)   $375,727,167     $375,727,167   0.00014760   $55,457.33          
                     
Fees to Be Paid   Total Registration Fee:   $375,727,167   N/A   $375,727,167   0.00014760   $55,457.33                
 
Carry Forward Securities
                         

Carry

Forward

Securities

  Equity  

Common

Stock,

par value

$0.0001 per

share

  457(o)   $25,727,167     $25,727,167   0.00014760   $3,797.33        
                 
Total Offering Amounts      $375,727,167 (2)     $55,457.33          
                 
Total Fees Previously Paid                   
                 
Total Fee Offsets          $3,797.33 (3)          
                 
Net Fee Due                $51,660                


 

(1)

The proposed maximum offering price per security will be determined from time to time by the registrant in connection with the issuance by the registrant of the securities registered hereunder and is not specified as to each class of security pursuant to General Instruction II.D. of Form S-3 under the Securities Act.

(2)

On November 30, 2020, the registrant filed an Automatic Shelf Registration Statement on Form S-3ASR (File No. 333-251022) (the “Prior Registration Statement”) and on March 4, 2022, the registrant filed a prospectus supplement, which registered the offer and sale of up to $400,000,000 of shares of the registrant’s common stock (the “Previous ATM Prospectus”) under the terms of an Open Market Sale Agreement (the “Sales Agreement”) with Jefferies LLC, of which $138,689,879 of securities remained unsold (the “Prior Unsold Securities”). On November 24, 2023, the registrant filed an Automatic Shelf Registration Statement on Form S-3ASR (File No. 333-275740) (the “Current Registration Statement”) and paid a registration fee of $7,615 which was filed for $138,689,870 of securities that may be issued or sold pursuant to the Previous ATM Prospectus. As of the date of this Prospectus, we have sold $374,272,833 pursuant to the Previous ATM Prospectus and $25,727,167 of shares remain unsold (the “Current Unsold Securities”) under the Previous ATM Prospectus. In connection with an amendment to the Sales Agreement, we are registering the offer and sale of $375,727,167 of shares which comprises of the Current Unsold Securities and an additional $350,000,000 of shares that may be issued or sold pursuant to this Prospectus.

(3)

Pursuant to Rule 457(p) under the Securities Act, the registrant hereby applies $3,797.33 of the registration fee previously paid in connection with the Current Registration Statement in connection with the Current Unsold Securities to offset the registration fees that are payable in connection with the registration of securities on this Prospectus. Pursuant to Rule 457(p) under the Securities Act, the offering of the Unsold Securities under the Current Registration Statement will be deemed terminated as of the date of effectiveness of this Prospectus.

(4)

In accordance with Rules 456(b) and 457(r) under the Securities Act of 1933, as amended, except with respect to the $51,660 to be paid in connection with the primary offering of common stock described in the table, which is being paid with the filing of this registration statement, the registrant is deferring payment of all registration fees and will pay the registration fees subsequently in advance or on a “pay-as-you-go” basis.

Table 2: Fee Offset Claims and Source

 

                       
     Registrant or Filer
Name
  Form or
Filing
Type
  File Number   Initial
Filing
Date
  Filing
Date
  Fee Offset
Claimed
  Security
Type
Associated
with Fee
Offset
Claimed
  Security
Title
Associated
with Fee
Offset
Claimed
  Unsold
Securities
Associated
with Fee
Offset
Claimed
  Unsold
Aggregate
Offering Amount
Associated with
Fee Offset
Claimed
 

Fee Paid

with Fee

Offset

Source

 
Rule 457(p)
                       

Fee

Offset

Claims

  Intellia Therapeutics, Inc.   S-3ASR   333-275740   November 24, 2023     $3,797.33   Unallocated (Universal) Shelf     $25,727,167   $25,727,167   $3,797.33 (1)

 

(1)

See Notes (2) and (3) under Table 1 above.